Paper31364692
Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.
Salazar-Austin N and 3 others. Am J Epidemiol, 2019. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration. Papers, record 31364692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31364692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epidemiology | Major topic |
| Tuberculosis | Major topic |
| HIV Infections | |
| History, 20th Century | |
| History, 21st Century | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 HD096973 | NICHD NIH HHS | United States | K23HD096973 | PubMed and NIH | NIH RePORTER |
| P30 AI094189 | NIAID NIH HHS | United States | P30AI094189 | PubMed and NIH | NIH RePORTER |
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 6366257 | Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents. | JAMA | 1984 | https://conductscience.org/library/papers/6366257 | PubMed |
| 3 | 9519950 | Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. | Lancet | 1998 | https://conductscience.org/library/papers/9519950 | PubMed |
| 4 | 9295239 | A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9295239 | PubMed |
| 5 | 10524579 | How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? | Int J Tuberc Lung Dis | 1999 | https://conductscience.org/library/papers/10524579 | PubMed |
| 6 | 12588714 | American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. | Am J Respir Crit Care Med | 2003 | https://conductscience.org/library/papers/12588714 | PubMed |
| 7 | 21732833 | New regimens to prevent tuberculosis in adults with HIV infection. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21732833 | PubMed |
| 8 | 25365974 | Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25365974 | PubMed |
| 9 | 29972628 | Maternal priorities for preventive therapy among HIV-positive pregnant women before and after delivery in South Africa: a best-worst scaling survey. | J Int AIDS Soc | 2018 | https://conductscience.org/library/papers/29972628 | PubMed |
| 10 | 15831840 | Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. | Am J Respir Crit Care Med | 2005 | https://conductscience.org/library/papers/15831840 | PubMed |
| 11 | 21849286 | Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21849286 | PubMed |
| 12 | 27522233 | The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. | Lancet Infect Dis | 2016 | https://conductscience.org/library/papers/27522233 | PubMed |
| 13 | 18989223 | Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. | J Acquir Immune Defic Syndr | 2008 | https://conductscience.org/library/papers/18989223 | PubMed |
| 14 | 17589190 | The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. | AIDS | 2007 | https://conductscience.org/library/papers/17589190 | PubMed |
| 15 | 10732934 | Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. | JAMA | 2000 | https://conductscience.org/library/papers/10732934 | PubMed |
| 16 | 27780211 | The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. | PLoS Med | 2016 | https://conductscience.org/library/papers/27780211 | PubMed |
| 17 | 11330495 | Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000. | MMWR Morb Mortal Wkly Rep | 2001 | https://conductscience.org/library/papers/11330495 | PubMed |
| 18 | 6754120 | Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. | Bull World Health Organ | 1982 | https://conductscience.org/library/papers/6754120 | PubMed |
| 19 | 29562983 | Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi. | Int J Tuberc Lung Dis | 2018 | https://conductscience.org/library/papers/29562983 | PubMed |
| 20 | 28763500 | Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. | PLoS One | 2017 | https://conductscience.org/library/papers/28763500 | PubMed |
| 21 | 1731596 | A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. | Am Rev Respir Dis | 1992 | https://conductscience.org/library/papers/1731596 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42182841 | Performance of TB Antigen-Based Skin Tests Amongst Healthcare Workers-Sevagram, India, 2023-2024. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42182841 | PubMed |
| 42110218 | Analytic Considerations for the Evaluation of Tuberculosis Preventative Therapy Effectiveness Among People Living with HIV. | Obs Stud | 2025 | https://conductscience.org/library/papers/42110218 | PubMed |
| 41798867 | Non-adherence and its predictors among pediatric household contacts on tuberculosis preventive therapy in the 3HP era: A multicenter observational study. | Ther Adv Infect Dis | 2026 | https://conductscience.org/library/papers/41798867 | PubMed |
| 41711404 | Breakthrough Tuberculosis in a Large Cohort of People Living With HIV on Preventive Treatment. | Trop Med Int Health | 2026 | https://conductscience.org/library/papers/41711404 | PubMed |
| 41172413 | Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil. | J Bras Pneumol | 2025 | https://conductscience.org/library/papers/41172413 | PubMed |
| 40986702 | The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis. | Am J Respir Crit Care Med | 2026 | https://conductscience.org/library/papers/40986702 | PubMed |
| 40349709 | Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial. | Lancet HIV | 2025 | https://conductscience.org/library/papers/40349709 | PubMed |
| 40092514 | Investigating low uptake of tuberculin skin testing when integrated with active case-finding for TB. | IJTLD Open | 2025 | https://conductscience.org/library/papers/40092514 | PubMed |
| 39131593 | Rethinking latent TB? Think again. | IJTLD Open | 2024 | https://conductscience.org/library/papers/39131593 | PubMed |
| 38734022 | Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. | Lancet Respir Med | 2024 | https://conductscience.org/library/papers/38734022 | PubMed |
| 38076017 | A case of oral tuberculous ulcer and literature review. | Clin Case Rep | 2023 | https://conductscience.org/library/papers/38076017 | PubMed |
| 37879092 | US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy. | Clin Infect Dis | 2024 | https://conductscience.org/library/papers/37879092 | PubMed |
| 36622148 | High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/36622148 | PubMed |
| 35576223 | Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study. | PLoS One | 2022 | https://conductscience.org/library/papers/35576223 | PubMed |
| 35086616 | The need for effective drugs for TB prevention: set your goals high, and don´t stop till you get there. | Int J Tuberc Lung Dis | 2022 | https://conductscience.org/library/papers/35086616 | PubMed |
| 34407070 | "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment. | PLoS One | 2021 | https://conductscience.org/library/papers/34407070 | PubMed |
| 32564076 | A Randomized Controlled Trial of Isoniazid to Prevent Mycobacterium tuberculosis Infection in Kenyan Human Immunodeficiency Virus-Exposed Uninfected Infants. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32564076 | PubMed |
| 32344637 | Vaccination with Alpha-Gal Protects Against Mycobacterial Infection in the Zebrafish Model of Tuberculosis. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32344637 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31364692
GET https://conductscience.org/api/papers/v1/31364692/references?page=2